Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
In Vivo ; 13(4): 343-8, 1999.
Article in English | MEDLINE | ID: mdl-10586376

ABSTRACT

BACKGROUND: Only few studies have tried to identify parameters at the time of diagnosis or during treatment that can assist the clinician in predicting the response to Cisplatin, 5-Fluorouracil +/- Folinic acid therapy in patients with head and neck squamous cell carcinoma (HNSCC). MATERIALS AND METHODS: The alkaline comet assay was used to measure both cellular hypoxia and DNA single-strand break (ssb) kinetics in individual lymphocytes of HNSCC patients undergoing combined therapy. The intracellular level of FdUMP, dUMP and mTHF were also measured during treatment. RESULTS: Two distinct types of cell populations were detected, from the less damaged population representing the hypoxic cells to the most damaged cells population representing the aerobic cells. We also described a direct relationship between DNA damage and repair and drug metabolism in lymphocytes and treatment efficacy. CONCLUSION: The response of tumors to chemotherapy is thought to be a function of the drug's pharmacological properties (the intracellular level of FdUMP and mTHF). In addition, a relationship between platinum DNA adduct levels in lymphocytes DNA (comet assay) and tumor response has been observed, suggesting that clinical resistance to platinum drugs is attributable to DNA repair functions of the host, and thus the degree of cytotoxicity is similar across all cell types.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Squamous Cell/drug therapy , DNA Damage , DNA Repair , Head and Neck Neoplasms/drug therapy , Lymphocytes/drug effects , Cell Hypoxia/drug effects , Cisplatin/therapeutic use , Cohort Studies , Comet Assay , Deoxyuracil Nucleotides/metabolism , Fluorodeoxyuridylate/metabolism , Fluorouracil/therapeutic use , Folic Acid/metabolism , Humans , Intracellular Fluid/metabolism , Leucovorin/therapeutic use , Lymphocytes/metabolism , Predictive Value of Tests , Thymidine Monophosphate/metabolism , Time Factors , Treatment Outcome
2.
Toxicol Appl Pharmacol ; 148(2): 195-204, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9473526

ABSTRACT

Cigarette smoking is a worldwide health problem and is the greatest risk factor for lung cancer. By activating procarcinogens, hepatic and extrahepatic cytochromes P450 can participate in lung carcinogenesis. Tobacco smoke contains numerous cytochrome P450 inducers, substrates, and inhibitors. In the present study we investigated, in male NMRI mice, the effects of cigarette smoke on hepatic and pulmonary cytochrome P450 expression and their possible role in the induction of DNA lesions such as DNA single strand breaks (SSB). Hepatic and pulmonary mouse cytochrome P450 isozymes involved in carcinogenesis (Cyp1a, 2b, 2e, 3a) were differently induced by cigarette smoke. Cyp2e1 mRNA was dramatically enhanced (12.7-fold increase) while Cyp2b10 mRNA remained unchanged and Cyp1a1 was decreased or not detected. Cyp3a protein and mRNA were not detected in lung, suggesting that this isozyme is not expressed in mouse pulmonary tissue. The SSB of DNA increased in lung and liver treated mice. In contrast no modification was observed in lymphocytes that barely expressed cytochromes P450. Cimetidine and propylene glycol reduced SSB of DNA induced by smoking in liver and lung cells. The inhibition (-70%) observed in lung following treatment by propylene glycol, a CYP2E1 inhibitor, suggested that this isozyme is at least in part involved in pulmonary DNA damage induced by tobacco smoke. The high concentration of CYP2E1 function and regulation in mammals suggests that this protein could be involved in pulmonary carcinogenesis in human smokers.


Subject(s)
Aryl Hydrocarbon Hydroxylases , Cytochrome P-450 Enzyme System/genetics , DNA Damage , DNA, Single-Stranded , Isoenzymes/genetics , Liver/enzymology , Lung/enzymology , Tobacco Smoke Pollution/adverse effects , Animals , Carboxyhemoglobin/analysis , Cytochrome P-450 CYP1A1/genetics , Cytochrome P-450 CYP2B1/genetics , Cytochrome P-450 CYP2E1/genetics , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme System/biosynthesis , Cytochromes b5/biosynthesis , Cytochromes b5/genetics , Enzyme Induction , Gene Expression Regulation, Enzymologic , Isoenzymes/biosynthesis , Lung Neoplasms/etiology , Male , Mice , Oxidoreductases, N-Demethylating/genetics , RNA, Messenger/analysis
3.
Mutat Res ; 375(2): 147-55, 1997 Apr 29.
Article in English | MEDLINE | ID: mdl-9202725

ABSTRACT

The genotoxicity of metronidazole (MZ) and dimetridazole (DZ) has been evaluated in human lymphocytes using the comet assay. The test has been performed using 3 doses (58.4, 175.2 and 292.1 microM for MZ; and 70.9, 212.6 and 354.3 microM for DZ) under 3 experimental protocols: aerobiosis, anaerobiosis (90% N2, 10% CO2) and with the presence of the microsomal fraction S9 mix. The effects of 4 antioxidants (8-hydroxyquinoline (8HQ), vitamin C (VitC), catalase (CAT) and superoxide dismutase (SOD), have been investigated on DNA damage generated by fixed concentrations of MZ (292.1 microM) and DZ (354.4 microM). In aerobic conditions, MZ and DZ produced significant dose-response relationships. The dose-related effects of both drugs decreased or were abolished in anaerobic conditions or in presence of S9 mix. 8HQ, VitC, CAT and SOD induced dose-related protective responses against DNA damage due to MZ and DZ. These findings suggest that MZ and DZ induce DNA damage in human lymphocytes through the futile cycle. The one-electron reduction of the drugs leads to the production of nitro radical anions. In the presence of oxygen, these radicals are reoxidized and generate oxygen-activated species.


Subject(s)
DNA Damage , DNA Mutational Analysis , Dimetridazole/pharmacology , Lymphocytes/drug effects , Metronidazole/pharmacology , Mutagenicity Tests/methods , Mutagens/pharmacology , Animals , Electrophoresis, Agar Gel/methods , Humans , Male , Microsomes, Liver/metabolism , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism
4.
Biochem Biophys Res Commun ; 219(2): 429-34, 1996 Feb 15.
Article in English | MEDLINE | ID: mdl-8605004

ABSTRACT

Several studies have shown in humans an association between renal carcinoma and cigarette smoking. Cigarette smoke contains numerous cytochrome P450 inducers and substrates. In the present study we investigated the effect of cigarette smoke on the regulation of murine cytochrome P450 expression in kidney and its possible role in the induction of single strand breaks in DNA. Results demonstrated that CYP2E1 (activity, protein, and MRNA) was induced by tobacco smoke (2.1, 5.6 and 20.8, respectively). We did not detect any CYP1A, CYP2B, and CYP3A using Western blot and RT-PCR experiments. We have analyzed the renal single strand breaks of DNA in control and treated mice. The results indicated an increase of single strand breaks of DNA in kidney from treated mice which paralleled the high inducibility of the CYP2E1. No significant difference was observed between lymphocytes (which expressed very low or undetectable cytochrome P450 levels) of control and treated mice.


Subject(s)
Cytochrome P-450 Enzyme System/biosynthesis , DNA Damage , Gene Expression Regulation, Enzymologic , Kidney/enzymology , Oxidoreductases, N-Demethylating/biosynthesis , Tobacco Smoke Pollution , Animals , Base Sequence , Cytochrome P-450 CYP2E1 , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , DNA Primers , DNA, Single-Stranded , Enzyme Induction , Humans , Male , Mice , Mice, Inbred Strains , Microsomes/enzymology , Molecular Sequence Data , Oxidoreductases, N-Demethylating/genetics , Oxidoreductases, N-Demethylating/metabolism , Polymerase Chain Reaction , Reference Values
SELECTION OF CITATIONS
SEARCH DETAIL
...